Clinical trials: Tamiflu reviewers respond to critics
Nature
.
2014 May 15;509(7500):288.
doi: 10.1038/509288a.
Authors
Peter Doshi
1
,
Tom Jefferson
2
Affiliations
1
University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
2
The Cochrane Collaboration, Rome, Italy.
PMID:
24828182
DOI:
10.1038/509288a
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents / pharmacology*
Humans
Influenza, Human / drug therapy*
Oseltamivir / pharmacology*
Strategic Stockpile*
Substances
Antiviral Agents
Oseltamivir